vigiRank for statistical signal detection in pharmacovigilance: First results from prospective real‐world use
Pharmacoepidemiology and Drug Safety2017Vol. 26(8), pp. 1006–1010
Citations Over TimeTop 14% of 2017 papers
Abstract
Combining multiple strength-of-evidence aspects as in vigiRank significantly outperformed disproportionality analysis alone in real-world pharmacovigilance signal detection, for VigiBase.
Related Papers
- → Strengthening standards, transparency, and collaboration to support medicine evaluation: Ten years of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP)(2018)46 cited
- → Building an ontology of adverse drug reactions for automated signal generation in pharmacovigilance(2005)45 cited
- → Drug induced hepatotoxicity: data from the Serbian pharmacovigilance database(2011)13 cited
- Application of pharmacoepidemiology in pharmacovigilance(2002)
- → Coding in Pharmacovigilance Using MedDRA: A Review(2022)